Search

everythinglearnresearchcommunity

for

Search:↓

Intralesional corticosteroids are the best for limited alopecia areata, oral steroids are less effective, and PRP is safe and promising, especially for children and severe cases.

New treatments for hair loss show promise but need more research to confirm safety and effectiveness.

There is no significant link between metabolic syndrome and alopecia areata.

Alopecia Areata is an autoimmune hair loss condition, with various treatments showing mixed effectiveness and no guaranteed cure.

Platelet-rich plasma and microneedling could potentially help hair regrowth in alopecia areata patients, but more research is needed.

Hair loss in three Southeast Asian women with kidney failure may be linked to their anemia treatment with erythropoietin.

Alopecia areata causes sudden hair loss, has genetic links, and can be managed but not cured.

Oxidative stress is important in causing alopecia areata.

Higher IL-21 levels may help predict alopecia areata activity.

Alopecia areata is an autoimmune condition causing hair loss, linked to genetic factors and immune system issues, with no cure yet.

PRP may help hair growth in alopecia areata without major side effects, but more research is needed.

The 2003 guidelines suggest that while some treatments can regrow hair in alopecia areata, none alter the disease's progression, and wigs may be the best option for extensive hair loss.

People with alopecia areata often have other health issues like skin diseases, metabolic syndrome, stomach infections, lupus, anemia, thyroid problems, mental health issues, vitamin D deficiency, and hearing and eye problems.

Some treatments, like corticosteroids and sensitizing agents, can help with alopecia areata, but more high-quality research is needed.

Topical immunotherapy, especially with DPCP, is effective for treating severe alopecia areata.

The combination of cyclosporine and PUVA might help treat severe alopecia areata.

Alopecia areata involves specific T-cells, unlike androgenetic alopecia.

Topical diphencyprone helped regrow hair in mice and rats with a condition similar to human hair loss.

A standard protocol for alopecia areata clinical trials was created to improve consistency and encourage more research.

Diphenylcyclopropenone is effective for treating alopecia areata but has a high relapse rate.

Both treatments are safe and effective, but anthralin may work better for some patients.

Low iron levels are strongly linked to chronic hair loss in women.

The research found specific signs to diagnose alopecia areata incognito and noted patients generally regrow hair after steroid treatment.

Some people with heavy hair shedding might actually have a hidden form of alopecia, which can be identified by specific hair changes.

Alopecia Areata Incognita causes widespread hair thinning, and treatment with systemic corticosteroids and psychiatric support can lead to remission.

The author clarified that Alopecia Areata Incognita (AAI) and diffuse Alopecia Areata (AA) are different conditions and the case discussed was actually AA, not AAI.

Alopecia areata patients have lower zinc, copper, and selenium levels than healthy people.

Dupilumab may cause hair loss, so patients should be monitored.

Minoxidil and finasteride treat hair loss; more research needed for other options.

Betamethasone valerate foam is more effective and safe for treating mild-to-moderate alopecia areata than betamethasone dipropionate lotion.